8-K
filed February 27, 2024, 6:59 PM ET
ticker UHT
CIK 0000798783
earnings
confidence high
sentiment negative
materiality 0.70
UHT Q4 2023 EPS $0.26 vs $0.41, FFO $0.82 vs $0.90; full year EPS $1.11 vs $1.53
UNIVERSAL HEALTH REALTY INCOME TRUST
2023-FY EPS reported
$1.11
revenue$95,575,000
- Q4 net income $3.6M ($0.26 diluted) vs $5.6M ($0.41) in Q4 2022.
- Adjusted net income Q4 $3.8M ($0.28) down from $5.6M ($0.41) on higher interest expense and one-time settlement.
- FFO Q4 $11.4M ($0.82) vs $12.4M ($0.90); full year FFO $44.6M ($3.23) vs $48.8M ($3.54).
- Divested vacant Corpus Christi facility for $3.9M (loss $232K); acquired McAllen MOB for $7.6M in Aug 2023.
- Q4 dividend $0.725/share paid Dec 29; CEO Alan Miller optimistic for 2024 portfolio growth.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
UNIVERSAL HEALTH REALTY INCOME TRUST reported the twelve-month period ended December 31, 2023 results: net income $15.4 million, EPS $1.11 per diluted share.
- Period
- the twelve-month period ended December 31, 2023
- Net income
- $15.4 million
- EPS
- $1.11 per diluted share
- Result
- reported results
Exact text from the filing
For the twelve-month period ended December 31, 2023, net income was $15.4 million, or $1.11 per diluted share
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
UNIVERSAL HEALTH REALTY INCOME TRUST reported the three-month period ended December 31, 2023 results: net income $3.6 million, EPS $.26 per diluted share.
- Period
- the three-month period ended December 31, 2023
- Net income
- $3.6 million
- EPS
- $.26 per diluted share
- Result
- reported results
Exact text from the filing
Universal Health Realty Income Trust (NYSE:UHT) announced today that for the three-month period ended December 31, 2023, net income was $3.6 million, or $.26 per diluted share
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.